Position history for FAYEZ SAROFIM & CO's holdings in ABBOTT LABORATORIES
FAYEZ SAROFIM & CO holds 4.3M shares of ABT (ABBOTT LABORATORIES), worth $439.6M as of 2026-Q1. The position was decreased (-4.4% shares). ABT represents 1.1% of FAYEZ SAROFIM & CO's portfolio.
Current Value
$439.6M
Current Shares
4.3M
Total Value Change
+$10.4M
Total Shares Change
+151,416
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 4.3M |
-4.4% |
| $439.6M |
| 1.1% |
| $113.61 |
0 |
| 2025-Q4 | Decreased | 4.5M | -0.8% | $561.4M | 1.3% | $125.15 | 0 |
| 2025-Q3 | Decreased | 4.5M | -0.1% | $609.2M | 1.4% | $131.85 | 0 |
| 2025-Q2 | Decreased | 4.5M | -2.1% | $619.1M | 1.5% | $132.52 | 0 |
| 2025-Q1 | Decreased | 4.6M | -1.2% | $617.7M | 1.5% | $128.41 | 0 |
| 2024-Q4 | Increased | 4.7M | +11.6% | $532.9M | 1.3% | $110.14 | 55 |
| 2024-Q3 | Increased | 4.2M | +1.4% | $477.7M | 1.2% | $109.27 | 50 |
| 2024-Q2 | Increased | 4.1M | +2.5% | $429.2M | 1.2% | $100.45 | 50 |